22 Nov 2005 - QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. and Osmetech Molecular Diagnostics., a division of Osmetech plc announced that they have entered into a distribution agreement. Pursuant to this agreement, Osmetech will incorporate certain preanalytical consumables and technologies from QIAGEN into Osmetech microarray-based solutions for use in diagnostic and research applications. QIAGEN's proprietary preanalytical technologies provide unmatched reproducibility and efficiency in molecular diagnostics applications.
 |
www.bionity.com/news/e/50389 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/50389 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |